课题基金 / 基金详情

MEDI-493 FOR PROPHYLAXIS OF SEVERE RSV DISEASE IN INFANTS

MEDI-493 FOR PROPHYLAXIS OF SEVERE RSV DISEASE IN INFANTS
MEDI-493 用于预防婴儿严重 RSV 疾病
批准号：
6279174
负责人：
MARK H SAWYER
金额：
$1.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279174
关键词：
antiviral agents bronchopulmonary dysplasia clinical research clinical trials drug administration rate /duration human subject human therapy evaluation infant human (0-1 year) otitis media outcomes research placebos premature infant human respiratory disorder chemotherapy respiratory disorder epidemiology respiratory infections respiratory syncytial virus

项目摘要

项目成果

MARK H SAWYER的其他基金

相似基金

相关文献

中文摘要
翻译
比较Medi-493与安慰剂的安全性和有效性 呼吸道合胞病毒(RSV)住院发生率 早产儿和患有支气管肺病的婴儿 发育不良。确定每月预防与安慰剂的效果比较 非呼吸道合胞病毒的住院结局、疾病严重程度、住院情况 呼吸系统疾病和中耳炎的发病率。
英文摘要
Compare the safety and efficacy of MEDI-493 to placebo for the reduction of the incidence of respiratory syncytial virus (rsv) hospitalization among infants born prematurely and infants with bronchopulmonary dysplasia. Determine the effect of monthly prophylaxis compared to placebo on hospitalization outcomes, disease severity, hospitalization for non-rsv respiratory disease and incidence of otitis media.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
San Diego-Influenza Coverage Extension (SD-ICE)
Impact of New Adolescent Vaccines
海外基金